Anez C. Ebrahim

Array ( [id] => 3761170 [patent_doc_number] => 05741778 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Method for treating Huntington\'s disease using glial cell line-derived neurotrophic factor (GDNF) protein product' [patent_app_type] => 1 [patent_app_number] => 8/618543 [patent_app_country] => US [patent_app_date] => 1996-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 12565 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741778.pdf [firstpage_image] =>[orig_patent_app_number] => 618543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3721571 [patent_doc_number] => 05700468 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Extracts of ginkgo biloba and their methods of preparation' [patent_app_type] => 1 [patent_app_number] => 8/615536 [patent_app_country] => US [patent_app_date] => 1996-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3329 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700468.pdf [firstpage_image] =>[orig_patent_app_number] => 615536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3813403 [patent_doc_number] => 05710127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Use of growth factor IGF-I and/or IGF-II' [patent_app_type] => 1 [patent_app_number] => 8/612177 [patent_app_country] => US [patent_app_date] => 1996-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2758 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710127.pdf [firstpage_image] =>[orig_patent_app_number] => 612177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621210 [patent_doc_number] => 05641749 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product' [patent_app_type] => 1 [patent_app_number] => 8/564458 [patent_app_country] => US [patent_app_date] => 1995-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14563 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641749.pdf [firstpage_image] =>[orig_patent_app_number] => 564458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621227 [patent_doc_number] => 05641750 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product' [patent_app_type] => 1 [patent_app_number] => 8/564833 [patent_app_country] => US [patent_app_date] => 1995-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 16970 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641750.pdf [firstpage_image] =>[orig_patent_app_number] => 564833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3826871 [patent_doc_number] => 05783560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Use of human growth hormone for preoperative administration' [patent_app_type] => 1 [patent_app_number] => 8/553375 [patent_app_country] => US [patent_app_date] => 1995-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2151 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783560.pdf [firstpage_image] =>[orig_patent_app_number] => 553375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3878267 [patent_doc_number] => 05804550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Peptide antagonists at glutamate and NMDA receptors' [patent_app_type] => 1 [patent_app_number] => 8/549798 [patent_app_country] => US [patent_app_date] => 1995-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 6968 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804550.pdf [firstpage_image] =>[orig_patent_app_number] => 549798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761155 [patent_doc_number] => 05741777 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Modulation of wound contraction by blocking protein tyrosine phosphatase' [patent_app_type] => 1 [patent_app_number] => 8/570615 [patent_app_country] => US [patent_app_date] => 1995-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 9359 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741777.pdf [firstpage_image] =>[orig_patent_app_number] => 570615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3826858 [patent_doc_number] => 05783559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Solution containing IGF-1' [patent_app_type] => 1 [patent_app_number] => 8/491902 [patent_app_country] => US [patent_app_date] => 1995-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5666 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783559.pdf [firstpage_image] =>[orig_patent_app_number] => 491902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732055 [patent_doc_number] => 05665706 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Nerve growth induction, stimulation and maintenance and enzyme potentiation' [patent_app_type] => 1 [patent_app_number] => 8/545043 [patent_app_country] => US [patent_app_date] => 1995-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2436 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665706.pdf [firstpage_image] =>[orig_patent_app_number] => 545043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3856672 [patent_doc_number] => 05705485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Gel formulations containing growth factors' [patent_app_type] => 1 [patent_app_number] => 8/539898 [patent_app_country] => US [patent_app_date] => 1995-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10349 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705485.pdf [firstpage_image] =>[orig_patent_app_number] => 539898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825256 [patent_doc_number] => 05731284 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Method for treating Alzheimer\'s disease using glial line-derived neurotrophic factor (GDNF) protein product' [patent_app_type] => 1 [patent_app_number] => 8/535682 [patent_app_country] => US [patent_app_date] => 1995-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15347 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731284.pdf [firstpage_image] =>[orig_patent_app_number] => 535682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3882386 [patent_doc_number] => 05798334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Pharmaceutical compositions for scarless tissue repair and regeneration and methods related thereto' [patent_app_type] => 1 [patent_app_number] => 8/535672 [patent_app_country] => US [patent_app_date] => 1995-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3791 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798334.pdf [firstpage_image] =>[orig_patent_app_number] => 535672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3496428 [patent_doc_number] => 05532217 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Process for the mineralization of collagen fibers, product produced thereby and use thereof to repair bone' [patent_app_type] => 1 [patent_app_number] => 8/524752 [patent_app_country] => US [patent_app_date] => 1995-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1380 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532217.pdf [firstpage_image] =>[orig_patent_app_number] => 524752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886361 [patent_doc_number] => 05723441 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Method of treating renal disease by administering IGF-I and IGFBP-3' [patent_app_type] => 1 [patent_app_number] => 8/521907 [patent_app_country] => US [patent_app_date] => 1995-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5118 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723441.pdf [firstpage_image] =>[orig_patent_app_number] => 521907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620846 [patent_doc_number] => 05688766 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Anticaries compositions' [patent_app_type] => 1 [patent_app_number] => 8/538165 [patent_app_country] => US [patent_app_date] => 1995-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3745 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688766.pdf [firstpage_image] =>[orig_patent_app_number] => 538165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805509 [patent_doc_number] => 05830857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Method of treating epilepsy' [patent_app_type] => 1 [patent_app_number] => 8/502348 [patent_app_country] => US [patent_app_date] => 1995-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 2198 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830857.pdf [firstpage_image] =>[orig_patent_app_number] => 502348 [rel_patent_id] =>[rel_patent_doc_number] =>)